热门资讯> 正文
RAPT Therapeutics宣布拟议公开募股
2025-10-22 04:17
- RAPT Therapeutics (NASDAQ:RAPT) announced on Tuesday that it has commenced an underwritten public offering of shares of its common stock.
- The company will grant the underwriters a 30-day purchase option of up to an additional 15% of the total number of common stock at the public offering price, less underwriting discounts and commissions.
More on RAPT Therapeutics
- RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria - Slideshow
- RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria Transcript
- RAPT Therapeutics jumps on mid-stage data for urticaria candidate
- Seeking Alpha’s Quant Rating on RAPT Therapeutics
- Historical earnings data for RAPT Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
